729 related articles for article (PubMed ID: 11351346)
1. Changes of phenotypic expression of prostatic antigen in secondary transitional cell carcinoma of the prostate: evidence for induction phenomenon as a mechanism for acquisition of prostatic antigens in prostatic transitional cell carcinoma.
Mai KT; Yazdi HM; Farmer J
Prostate; 2001 May; 47(3):172-82. PubMed ID: 11351346
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical detection of prostate-specific antigen expression in primary urothelial carcinoma of the urinary bladder.
Chen JC; Ho CL; Tsai HW; Tzai TS; Liu HS; Chow NH; Yang WH; Cheng HL
Anticancer Res; 2008; 28(6B):4149-54. PubMed ID: 19192675
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder.
Lane Z; Hansel DE; Epstein JI
Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358
[TBL] [Abstract][Full Text] [Related]
4. Immunocytochemical study of urine cytological preparations from secondary prostatic adenocarcinoma involving the urinary bladder.
Mai KT; Ahmed I; Robertson SJ; Belanger EC; Veinot JP; Islam S
Diagn Cytopathol; 2008 Oct; 36(10):715-20. PubMed ID: 18773445
[TBL] [Abstract][Full Text] [Related]
5. Primary seminal vesicle carcinoma: an immunohistochemical analysis of four cases.
Ormsby AH; Haskell R; Jones D; Goldblum JR
Mod Pathol; 2000 Jan; 13(1):46-51. PubMed ID: 10658909
[TBL] [Abstract][Full Text] [Related]
6. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
[TBL] [Abstract][Full Text] [Related]
7. Prostatic transitional cell carcinoma: concept of its pathogenesis and classification.
Schujman E; Mukamel E; Slutzker D; Mor C; Servadio C
Isr J Med Sci; 1983 Sep; 19(9):794-800. PubMed ID: 6643016
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical differentiation of high-grade prostate carcinoma from urothelial carcinoma.
Chuang AY; DeMarzo AM; Veltri RW; Sharma RB; Bieberich CJ; Epstein JI
Am J Surg Pathol; 2007 Aug; 31(8):1246-55. PubMed ID: 17667550
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of transitional cell carcinoma in the prostatic urethra and prostate in the cystoprostatectomy specimen. Incidence, characteristics and preoperative detection.
Liedberg F; Anderson H; Bläckberg M; Chebil G; Davidsson T; Gudjonsson S; Jahnson S; Olsson H; Månsson W
Scand J Urol Nephrol; 2007; 41(4):290-6. PubMed ID: 17763219
[TBL] [Abstract][Full Text] [Related]
10. Secondary prostatic adenocarcinoma: a cytopathological study of 50 cases.
Mai KT; Roustan Delatour NL; Assiri A; Al-Maghrabi H
Diagn Cytopathol; 2007 Feb; 35(2):91-5. PubMed ID: 17230567
[TBL] [Abstract][Full Text] [Related]
11. The role of P501S and PSA in the diagnosis of metastatic adenocarcinoma of the prostate.
Sheridan T; Herawi M; Epstein JI; Illei PB
Am J Surg Pathol; 2007 Sep; 31(9):1351-5. PubMed ID: 17721190
[TBL] [Abstract][Full Text] [Related]
12. Naturally occurring prostate cancer antigen-specific T cell responses of a Th1 phenotype can be detected in patients with prostate cancer.
McNeel DG; Nguyen LD; Ellis WJ; Higano CS; Lange PH; Disis ML
Prostate; 2001 May; 47(3):222-9. PubMed ID: 11351352
[TBL] [Abstract][Full Text] [Related]
13. The relation of prostatic acid phosphatase and prostate specific antigen with tumour grade in prostatic adenocarcinoma: an immunohistochemical study.
Ersev A; Ersev D; Turkeri L; Ilker Y; Simsek F; Kullu S; Akdas A
Prog Clin Biol Res; 1990; 357():129-34. PubMed ID: 1699237
[TBL] [Abstract][Full Text] [Related]
14. Primary and secondary prostatic adenocarcinoma of the urinary bladder.
Mai KT; Ford JC; Morash C; Gerridzen R
Hum Pathol; 2001 Apr; 32(4):434-40. PubMed ID: 11331961
[TBL] [Abstract][Full Text] [Related]
15. Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma.
Bassily NH; Vallorosi CJ; Akdas G; Montie JE; Rubin MA
Am J Clin Pathol; 2000 Mar; 113(3):383-8. PubMed ID: 10705819
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma.
Genega EM; Hutchinson B; Reuter VE; Gaudin PB
Mod Pathol; 2000 Nov; 13(11):1186-91. PubMed ID: 11106075
[TBL] [Abstract][Full Text] [Related]
17. Morphological features correlation with serum tumour markers in prostatic carcinoma.
Afzal S; Ahmad M; Mushtaq S; Mubarik A; Qureshi AH; Khan SA
J Coll Physicians Surg Pak; 2003 Sep; 13(9):511-4. PubMed ID: 12971871
[TBL] [Abstract][Full Text] [Related]
18. [Determination of prostatic specific antigen and prostatic acid phosphatase as tumor markers of cancer of the prostate].
Morote Robles J; de Torres Mateos JA
Arch Esp Urol; 1989; 42 Suppl 2():124-30. PubMed ID: 2484148
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical profile of high-grade urothelial bladder carcinoma and prostate adenocarcinoma.
Mhawech P; Uchida T; Pelte MF
Hum Pathol; 2002 Nov; 33(11):1136-40. PubMed ID: 12454820
[TBL] [Abstract][Full Text] [Related]
20. Transitional cell carcinoma of the prostate: clinicopathologic study of 50 cases.
Cheville JC; Dundore PA; Bostwick DG; Lieber MM; Batts KP; Sebo TJ; Farrow GM
Cancer; 1998 Feb; 82(4):703-7. PubMed ID: 9477103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]